It's not PCR + PocT.. It's PCR + immunoassay for Sars-cov-2 which is already in practice. Immunoassay are run on immunoassay analysers that are already present in most pathology labs around the country. It is a quantitative test for sars-cov-2 which means it measure how much virus is in your system rather than PocT which is a qualitative test that tells you if you are positive or not. PocT has no place at least in Australia.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-1208
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable